|Skip left side navigation and go to content||
Inventions arising from the intramural research activities at NIH are available to the private sector for further research and development and eventual commercialization through licensing of that technology. If an entity would like to acquire either an unpatented material or a patented or patent-pending technology for commercial purposes, a Commercial Evaluation License, a Biological Materials License, or an Exclusive/Nonexclusive License is required.
Other NIH technologies available for transfer, partnership, or licensing:
To use TechFinder, click on the link above.
Last Updated: March 2014